Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 158,463 | 96,024 | 66,686 | 46,373 | 44,400 |
| Gross Profit | 158,463 | 96,024 | 66,686 | 46,373 | 44,400 |
| Operating Expenses | 207,148 | 154,369 | 196,338 | 76,351 | 67,167 |
| Operating Income | -48,685 | -58,345 | -129,652 | -29,978 | -22,767 |
| Interest Expense | 10,177 | 5,028 | 9,770 | 9,146 | 9,709 |
| Other Income | 9,616 | 10,212 | 9,681 | 24,612 | 35,135 |
| Pre-tax Income | -49,246 | -53,161 | -129,741 | -14,512 | 2,659 |
| Income Tax | 47 | 80 | 73 | 42 | 12 |
| Net Income Continuous | -49,293 | -53,241 | -129,814 | -14,554 | 2,647 |
| Net Income Discontinuous | -117,284 | N/A | N/A | N/A | N/A |
| Net Income | $-166,577 | $-53,241 | $-129,814 | $-14,554 | $2,647 |
| EPS Basic Total Ops | -1.60 | -0.56 | -1.40 | -0.16 | 0.03 |
| EPS Basic Continuous Ops | -0.47 | -0.56 | -1.40 | -0.16 | 0.03 |
| EPS Basic Discontinuous Ops | -1.13 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -1.60 | -0.56 | -1.40 | -0.16 | 0.03 |
| EPS Diluted Continuous Ops | -0.47 | -0.56 | -1.40 | -0.16 | 0.03 |
| EPS Diluted Discontinuous Ops | -1.13 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $6,212 | $-43,277 | $-119,157 | $-23,816 | $-17,264 |